Notice2022-24918
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 16, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a new proposed information collection project titled TRANSCEND: Transgender status-neutral community-to-clinic models to end the HIV epidemic. This project is designed to collect standardized program evaluation data from the clinics and community- based organizations who receive federal funds for HIV prevention and care activities.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 220 (Wednesday, November 16, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 220 (Wednesday, November 16, 2022)]
[Notices]
[Pages 68694-68695]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24918]
[[Page 68694]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-23AP; Docket No. CDC-2022-0128]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a new proposed information collection project
titled TRANSCEND: Transgender status-neutral community-to-clinic models
to end the HIV epidemic. This project is designed to collect
standardized program evaluation data from the clinics and community-
based organizations who receive federal funds for HIV prevention and
care activities.
DATES: CDC must receive written comments on or before January 17, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0128 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: <a href="/cdn-cgi/l/email-protection#aac5c7c8eac9cec984cdc5dc"><span class="__cf_email__" data-cfemail="dcb3b1be9cbfb8bff2bbb3aa">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), federal agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
TRANSCEND: Transgender status-neutral community-to-clinic models to
end the HIV epidemic--New--National Center for HIV, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Transgender (TG) persons, especially transgender women (TGW), have
a high prevalence of HIV and lifetime risk of acquiring HIV. In the
2019-2020 National HIV Behavioral Surveillance Trans cycle, 42% of TGW
tested positive for HIV. Racial/ethnic disparities were also found,
with HIV positivity rates of 62% among Black/African American TGW and
35% among Hispanic/Latina TGW compared to 17% among White TGW. Despite
the disproportionate burden of HIV among TGW, receipt of HIV prevention
and care services have been suboptimal. Among TG persons, 92% reported
that they were aware of pre-exposure prophylaxis (PrEP) but only 32%
had used it. In 2019, viral suppression among persons with diagnosed
HIV was 67% among TGW. Large proportions of TG persons experience
poverty, homelessness, abuse, and have substance use or mental health
disorders, which impact access to and utilization of HIV prevention and
care services. Many TG persons seek gender-affirming care, including
hormone therapy, at transgender healthcare organizations (TG clinics),
and these encounters provide opportunities for HIV testing and status-
neutral HIV services.
In the proposed demonstration project, TG clinics and transgender-
serving community-based organizations (CBOs) will work collaboratively
to develop and evaluate community-to-clinic models to provide
integrated status-neutral HIV prevention and care services, gender-
affirming services including hormone therapy, and primary healthcare,
as well as to ensure access to mental health, substance use, and social
support services. All services will be culturally and linguistically
responsive for TG persons to ensure that they feel welcomed, heard, and
cared for. The recipients will also participate in a national learning
collaborative to share lessons learned and best practices for TG clinic
and TG CBO partnerships to provide status-neutral, community-to-clinic
services for TG persons.
This collection of deidentified data will allow CDC to assist TG
clinics and CBOs in monitoring and evaluating their programs and to
identify best practices for providing status-neutral HIV services and
comprehensive healthcare for TG persons and for community-to-clinic
models of service provision. Longitudinal person-level data collection
will occur through the clinic's electronic health record (EHR) and a
database shared between clinic and CBOs, and additional program
evaluation data will be collected through client surveys.
CDC requests OMB approval for an estimated 329 annual burden hours
for the recipients to collect, enter or upload, and report client
demographic and behavioral characteristics, client data from the EHR,
and client surveys. There are no other costs to respondents other than
their time to participate.
[[Page 68695]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
TRANSCEND Recipient Data Electronic 4 2 8 64
Manager. Health Record
Data Form.
TRANSCEND Recipient Data Client Info Form 4 2 2 16
Manager.
---------------------------------------------------------------
TRANSCEND Clients............. Client Info Form 1,000 1 5/60 83
TRANSCEND CBO Staff........... Client Info Form 8 100 5/60 67
TRANSCEND Clients............. Client Program 1,000 1 5/60 83
Evaluation
Survey.
TRANSCEND Recipient Data Client Program 4 2 2 16
Manager. Evaluation
Survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 329
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-24918 Filed 11-15-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 16, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.